We developed a protocol to determine the copy number of the HER2 gene by quantitative RT-PCR/qPCR using SYBR green dye I, with which we examined 10 blind DNA samples from the tumor tissue of breast cancer patients. Here, ERBB2 is linked to breast carcinoma.